Recent Quotes (30 days)

You have no recent quotes
chg | %

AstraZeneca plc news

   Watch this stock
Showing stories 1 - 10 of about 67   

Articles published

AZN 4,709.69 -1.31 (-0.03%)
price chart
AstraZeneca Is Undervalued
AstraZeneca plc is a global biopharmaceutical company. AstraZeneca discovers, develops and commercializes prescription medicines for six areas of healthcare: Cardiovascular, Gastrointestinal, Infection, Neuroscience, Oncology, and Respiratory and ...
Amylin Said to Attract Interest From Pfizer, AstraZeneca
AstraZeneca Plc (AZN), the U.K.'s second-biggest drugmaker, shouldn't get a further reduction in an antitrust fine of 52.5 million euros ($67.5 million), an adviser to the European Union's highest court said.
Related articles »  
FTSE CLOSE: Market steadies in positive territory as bank shares rise
Marston's PLC, Numis, Buy. ICAP PLC, Numis, Hold. Gemfields PLC, Numis, Buy. Carr's Milli... Numis, Hold. B&M European... Numis, Add. Amlin PLC, Numis, Add. AGA Rangemas... Numis, Add. B&M European... Citigroup, Buy. AstraZeneca PLC, Citigroup ...
Related articles »  
Shareholder spring: After the unseating of big beasts, no overpaid executive ...
Sly Bailey of Trinity Mirror and David Brennan of AstraZeneca have been defenestrated due to a toxic mix of large rewards and lacklustre returns.
Related articles »  
EU Joins Widening Push to Find New Antibiotics
"Antibiotics are fundamental for the practice of medicine," says John Rex, vice-president of clinical infection at AstraZeneca PLC." Without them you cannot get your heart valve replaced, take care of a premature infant, get your cancer treated, or ...
Related articles »  
Museum re-opens after 'radical' refurbishment
A Roman coffin that's not been on display for 30 years is now among the exhibits at the recently refurbished museum of Archaeology and Anthropology in Cambridge.
Related articles »  
Boards wake up to a shareholder spring
Two weeks ago David Brennan, chief executive of AstraZeneca, bowed to pressure from the pharmaceutical group's top shareholders and stepped down at the annual meeting.
Related articles »  
10 companies that could boost your income
Income-seekers have had a tough time of late. With interest rates on deposits at an all-time low, people relying on their savings for income have seen their pots shrink, and then shrink again.
Simon Brocklehurst, co-founder of Ash Biotech
Since being acquired by AstraZeneca, CAT's technology has helped create an early stage biologics pipeline for AZ that looks to have some real potential.
US to Seek New Uses for Abandoned Drugs
The National Institutes of Health initially will work with Pfizer Inc., Eli Lilly & Co. and AstraZeneca PLC to match abandoned drugs with researchers from universities, hospitals and the NIH.
Related articles »